Expertise in
11
conditions

Dr. Troy W. Wadsworth

Hematology
Multicare Cancer Institute-Auburn
121 N Division St Ste 100, 
Auburn, WA 
Accepting New Patients
Offers Telehealth
Expertise in
11
conditions
Multicare Cancer Institute-Auburn
121 N Division St Ste 100, 
Auburn, WA 

Overview

Troy Wadsworth is a Hematologist practicing medicine in Auburn, Washington.

Dr. Wadsworth is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, and ALK-Positive Non-Small Cell Lung Cancer.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 2 clinical trials. Dr. Wadsworth is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in PA

Hospital Affiliations

Multicare Auburn Medical Center
Tacoma General Allenmore Hospital
Multicare Covington Medical Center
Multicare Good Samaritan Hospital

Languages Spoken

English
Hindi
Japanese
Korean
Mandarin
Punjabi
Russian
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Group Health Cooperative
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Lifewise

Accepted plan types not found. Please verify directly with the provider.

Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PacificSource
  • PPO
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Multicare Cancer Institute-Auburn
121 N Division St Ste 100, Auburn, WA 98001

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase II Trial of Metronomic Eribulin (Halaven) in Pretreated Metastatic Breast Cancer (MBC)
Phase II Trial of Metronomic Eribulin (Halaven) in Pretreated Metastatic Breast Cancer (MBC)
Enrollment Status: Completed
Publish Date: July 23, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2
Feasibility and Outcomes of Allogeneic Hematopoietic Cell Transplantation (HCT) Compared to Conventional Therapy for Older and Medically Infirm Patients Diagnosed With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes: A Prospective Observational Study
Feasibility and Outcomes of Allogeneic Hematopoietic Cell Transplantation (HCT) Compared to Conventional Therapy for Older and Medically Infirm Patients Diagnosed With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes: A Prospective Observational Study
Enrollment Status: Completed
Publish Date: November 15, 2019
View 1 Less Clinical Trial

1 Total Publications

A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study.
A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 02, 2019
Similar Doctors
Expertise in
21
conditions
Expertise in
21
conditions
Referral may be required

Rachel Loschiavo PA-C

825 Eastlake Ave E, 
Seattle, WA 
 (22.4 miles away)
206-288-1000
Languages Spoken:
English, Farsi, Hebrew, Russian, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Mazyar Shadman is a Hematologist practicing medicine in Seattle, Washington. Dr. Shadman is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Non-Hodgkin Lymphoma, and Bone Marrow Transplant. Dr. Shadman is currently accepting new patients.

Expertise in
21
conditions
Expertise in
21
conditions
Referral may be required

Rachel Loschiavo PA-C

825 Eastlake Ave E, 
Seattle, WA 
 (22.4 miles away)
855-557-0555
Languages Spoken:
English, German, Portuguese, Russian, Ukrainian
See accepted insurances
Accepting New Patients
Offers Telehealth

Andrei Shustov is a Hematologist practicing medicine in Seattle, Washington. Dr. Shustov is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Anaplastic Large Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Shustov is currently accepting new patients.

Expertise in
18
conditions
Dr. Chaitra Ujjani
Hematology | Oncology
Expertise in
18
conditions
Dr. Chaitra Ujjani
Hematology | Oncology
Referral may be required

Rachel Loschiavo PA-C

825 Eastlake Ave E, 
Seattle, WA 
 (22.4 miles away)
206-606-1955
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Chaitra Ujjani is a Hematologist and an Oncologist practicing medicine in Seattle, Washington. Dr. Ujjani is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Follicular Lymphoma, Chronic Lymphocytic Leukemia (CLL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Ujjani is currently accepting new patients.

Frequently Asked Questions about Dr. Troy W. Wadsworth

How do I make an appointment with Dr. Troy W. Wadsworth?

You can book an appointment with Dr. Troy W. Wadsworth by calling their office at 253-876-8200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Troy W. Wadsworth a top-rated expert for Muscle Invasive Bladder Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Troy W. Wadsworth is classified as an Advanced expert for Muscle Invasive Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Troy W. Wadsworth specialize in?

While Dr. Troy W. Wadsworth is a Hematology, they have specific expertise in Muscle Invasive Bladder Cancer, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Schnitzler Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Troy W. Wadsworth participate in research or clinical trials?

Yes. Dr. Troy W. Wadsworth has published 1 articles and abstracts on conditions like Muscle Invasive Bladder Cancer. You can view a list of Dr. Troy W. Wadsworth's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Troy W. Wadsworth accept my insurance?

Dr. Troy W. Wadsworth accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 253-876-8200 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wadsworth's expertise for a condition
ConditionClose
      View All 11 Advanced Conditions
      View All 40 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile